Generics - Sanofi, Markets & Marketing

Filter

Current filters:

SanofiMarkets & Marketing

Popular Filters

India’s Lupin launches insulin glargine analogue Basugine

11-08-2014

Indian generic drugmaker Lupin has entered into a strategic distribution agreement with LG Life Sciences…

BasugineBiosimilarsDiabetesGenericsIndiaLantusLG Life SciencesLupinMarkets & MarketingPeptide hormonesRecombinant proteinsSanofi

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

27-01-2014

Brazil's Development Bank (BNDS) plans to invest up to 10 billion real ($4.2 billion) in the production…

BiotechnologyBrazilFinancialGenericsHypermarcasMarkets & MarketingProductionSanofiSouth America

Mylan extends deal with Bioton to biosimilar insulins, as Actavis pulls out of JV

14-02-2013

US generic drugmaker Mylan (Nasdaq: MYL) said yesterday that it has entered into a definitive agreement…

ActavisBiotechnologyBiotonDiabetesEli LillyGenericsHumalogLantusLicensingMarkets & MarketingMylan LaboratoriesNovo NordiskNovoLogSanofi

Pharma vs the world: Big Pharma caught between investors and public

23-09-2012

Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Teva launches generic Aprovel in UK

30-08-2012

The UK subsidiary of Israel's Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic…

AprovelBristol-Myers SquibbCardio-vascularEuropeGenericsMarkets & MarketingSanofiTeva Pharmaceutical Industries

Sanofi and Bayer consider Russian expansion, product launches

28-03-2012

Two European drug majors - France-based Sanofi (Euronext: SAN) and German company Bayer (BAY: DE) have…

BayerEuropeGenericsInsulinMarkets & MarketingPharmaceuticalSanofi

Sanofi considers expanding in Ukraine pharma market

24-02-2012

French drug major Sanofi (Euronext: SAN) is considering a massive expansion into the Ukrainian pharmaceutical…

EuropeGenericsMarkets & MarketingPharmaceuticalSanofi

Back to top